Prognosis
U.S. Vaccine Push Weakened Further as Court Chops Business Mandate
New vaccinations have stalled despite incentives and penalties
A healthcare worker administers a Pfizer-BioNTech Covid-19 vaccine at a vaccination site in San Francisco.
Photographer: David Paul Morris/BloombergThis article is for subscribers only.
The number of new people getting the Covid-19 vaccine is at one of the lowest points since the rollout began, according to a review of the latest U.S. government data.
While millions of doses are being administered each week, the majority of those are now booster shots for people who have already gotten their first round of injections. Vaccination rates are high in many major cities, but remain low in other parts of the country—with little sign of increase. And the Biden administration’s most potent tool to push vaccinations has been wiped out by the Supreme Court.